Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Neurochem. 2017 Nov 6;144(5):634–643. doi: 10.1111/jnc.14218

Figure 6.

Figure 6

Comparison of individual biomarkers between patients with Binswanger ‘s disease (BD) and non-BD, including multiple infarcts (MI), mixed Alzheimer’s disease/vascular cognitive impairment (MX), leucoaraiosis (LA). (A) Albumin index (ratio of cerebrospinal fluid albumin to serum albumin) shows significant elevation in BD, suggesting disruption of the blood-brain barrier. (B) N-acetylaspartate (NAA) measured in white matter by proton magnetic resonance spectroscopy (1H-MRS) was significantly lower in BD due to ischaemic injury to the white matter. (C) Matrix metalloproteinase-2 (MMP-2) index was significantly reduced in BD. (D) Mean blood-brain barrier permeability, Ki, measured by dynamic contrast-enhanced MRI was elevated in BD. Numbers in parentheses represent statistical significance.(Rosenberg et al. 2015)